Produkte von LC Laboratories

LC Laboratories

LC Laboratories aus Woburn, Massachusetts liefert seit 1980 Small Molecules für die Forschung. Zahlreiche Hersteller von Reagenzien verkaufen die hochwertigen Produkte von LC Laboratories unter ihrem eigenen Label. Wenn Sie im Bereich Signaltransduktion, Onkologie oder anderer präklinischer Forschung unterwegs sind, haben Sie sich wahrscheinlich von Anfang an, bewusst oder unbewusst, auf LC Labs-Produkte verlassen.

Mehr Informationen unter: www.lclabs.com

3 von 12 Seiten
Für die Filterung wurden keine Ergebnisse gefunden!
Nilotinib, Free Base (Tasigna, AMN-107, CAS 641571-10-0), >99%
Nilotinib, Free Base (Tasigna, AMN-107, CAS 641571-10-0),...

Artikelnummer: LC-N-8207_1g

Soluble in DMSO at 50 mg/mL, very poorly soluble in ethanol, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-20 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Schlagworte: AMN107,...
Anwendung: Bcr inhibitor, Abl inhibitor
CAS 641571-10-0
MW: 529,52 D
ab 92,00 €
Bewerten
Nintedanib, Ethanesulfonate Salt
Nintedanib, Ethanesulfonate Salt

Artikelnummer: LC-N-9055_2g

Solubility: Soluble in DMSO at 25 mg/mL with warming, soluble in ethanol at 8 mg/mL with warming, soluble in water at 25 mg/mL with warming, buffers, serum, or other additives may increase or decrease the aqueous solubility. This research compound is the ethanesulfonate salt form of nintedanib. Nintedanib is an...
Schlagworte: BIBF1120 Esylate, Intedanib Esylate, Nintedanib Esylate
Anwendung: Antifibrosis, Tyrosine kinase inhibitor
CAS 656247-18-6
MW: 649.76 D
ab 82,00 €
Bewerten
Nintedanib, Free Base
Nintedanib, Free Base

Artikelnummer: LC-N-9077_25mg

Solubility: Soluble in DMSO at 25 mg/mL with warming, very poorly soluble in ethanol, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-20 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility. This product was previously Cat. No. I-9077,...
Schlagworte: BIBF1120, Intedanib, Vargatef
Anwendung: Antifibrosis, Tyrosine kinase inhibitor
CAS 656247-17-5
MW: 539.62 D
ab 82,00 €
Bewerten
PD 325901, Free Base (MEK1/2 Inhibitor III, PD0325901, 391210-10-9), >99%
PD 325901, Free Base (MEK1/2 Inhibitor III, PD0325901,...

Artikelnummer: LC-P-9688_5mg

Soluble in DMSO at 12 mg/mL, soluble in ethanol at 6.3 mg/mL with slight warming, very poorly soluble in water, maximum solubility in plain water is estimated to be about 50-100 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Schlagworte: N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide
Anwendung: MEK inhibitor
CAS 391210-10-9
MW: 482,19 D
ab 88,00 €
Bewerten
SP600125 (Anthra(1,9-<i>cd</i>)pyrazol-6(2<i>H</i>)-one, 1,9-Pyrazoloanthrone, Anthrapyrazolone, JNK
SP600125 (Anthra(1,9-<i>cd</i>)pyrazol-6(2<i>H</i>)-one,...

Artikelnummer: LC-S-7979_100mg

Prepare initial stock solutions in DMSO (soluble at 65 mg/mL) for in vitro use, solubility in ethanol or water is low
Schlagworte: 1PMV, NSC 75890, Pyrazolanthrone, anthra[1,9-cd]pyrazol-6(2H)-one
Anwendung: JNK inhibitor
CAS 129-56-6
MW: 220,23 D
ab 93,00 €
Bewerten
Sorafenib, Free Base (Sorafenib, Bay 43-9006, Nexavar, CAS 284461-73-0), >99%
Sorafenib, Free Base (Sorafenib, Bay 43-9006, Nexavar,...

Artikelnummer: LC-S-8599_1g

Soluble in DMSO at 200 mg/mL, soluble in ethanol at 3.3 mg/mL with warming, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-50 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Schlagworte: Sorafenib, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
Anwendung: Kinase inhibitor
CAS 284461-73-0
MW: 464,82 D
ab 79,00 €
Bewerten
Sunitinib, Malate Salt (Sunitinib Maleate, Sutent, SU-11248, PHA-290940AD, PNU-290940AD, CAS 341031-
Sunitinib, Malate Salt (Sunitinib Maleate, Sutent,...

Artikelnummer: LC-S-8803_300mg

Soluble in DMSO at 40 mg/mL, very poorly soluble in ethanol, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-50 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Schlagworte: SU11248, Sutent(TM),...
Anwendung: Receptor tyrosine kinase inhibitor
CAS 341031-54-7
MW: 532,56 D
ab 88,00 €
Bewerten
Tofacitinib, Free Base (Tasocitinib, CP-690550, Xeljanz, CAS 477600-75-2), >99%
Tofacitinib, Free Base (Tasocitinib, CP-690550, Xeljanz,...

Artikelnummer: LC-T-1377_200mg

Soluble in DMSO at 100 mg/mL, soluble in ethanol at 100 mg/mL, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-20 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Anwendung: JAK3 inhibitor
CAS 477600-75-2
MW: 312,37 D
ab 94,00 €
Bewerten
Tofacitinib, Citrate Salt (Tasocitinib Citrate, CP-690550 Citrate, CP-690550-10, Xeljanz, CAS 540737
Tofacitinib, Citrate Salt (Tasocitinib Citrate, CP-690550...

Artikelnummer: LC-T-1399_1g

Soluble in DMSO
Schlagworte: Tofacitinib citrate,...
Anwendung: JAK inhibitor
CAS 540737-29-9
MW: 504,49 D
ab 94,00 €
Bewerten
Thiazovivin, Free Base (Tzv, CAS 1226056-71-8), >99%
Thiazovivin, Free Base (Tzv, CAS 1226056-71-8), >99%

Artikelnummer: LC-T-9753_25mg

Soluble in DMSO
Schlagworte: Tzv, N-(phenylmethyl)-2-(4-pyrimidinylamino)-4-thiazolecarboxamide
Anwendung: Cell-permeable ROCK inhibitor
CAS 1226056-71-8
MW: 311,36 D
ab 134,00 €
Bewerten
Temsirolimus, >99%
Temsirolimus, >99%

Artikelnummer: LC-T-8040_10mg

Soluble in DMSO at 200 mg/mL, soluble in ethanol at 200 mg/mL, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-20 µM
Schlagworte: GCCI-779
Anwendung: mTOR inhibitor
CAS 162635-04-3
MW: 1030.29 D
ab 92,00 €
Bewerten
Osimertinib, Methanesulfonate Salt
Osimertinib, Methanesulfonate Salt

Artikelnummer: LC-O-7233_25mg

Soluble in DMSO. This research compound is the methanesulfonate salt form of osimertinib. Osimertinib, also known as AZD9291, is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). EGFR TKIs have been used to treat patients with non-small-cell lung cancer (NSCLC) harboring sensitizing...
Schlagworte: AZD9291, Mereletinib
Anwendung: Antineoplastic, EGFR tyrosine kinase inhibitor
CAS 1421373-66-1
MW: 595.72 D
ab 87,00 €
Bewerten
3 von 12 Seiten